Oxford University – AstraZeneca Publish Positive Coronavirus Vaccine Data in Lancet Study
Oxford University, along with Britain’s AstraZeneca plc (AZN) – Get Report published promising data from an early stage trial of a key coronavirus vaccine study Monday in London that could lead to its broader use before the end of the year.
The details, published in the U.K. medical journal The Lancet, showed what the two groups described as humoral and cellular immune responses in human trials, with an acceptable safety profile. The study also showed ‘potent’ cellular and humoral immunogenicity in all 1,077 participants in the Phase 1/Phase II study.
‘The interim Phase I/II data for our coronavirus vaccine shows that the vaccine did not lead to any unexpected reactions and had a similar safety profile to previous vaccines of this type,” said Andrew Pollard, chief investigator of the…